Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Rivaroxaban or Warfarin
Locations
1
Japan
Yukio Ozaki
Nagoya, Aichi-ken, Japan
Start Date
January 1, 2014
Primary Completion Date
December 1, 2018
Completion Date
December 1, 2022
Last Updated
January 3, 2023
NCT06258538
NCT05093673
NCT07371455
NCT06870812
NCT07253181
NCT05147792
Lead Sponsor
Fujita Health University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions